Experimental cell transplantation

 
Hanne Scholz<br>Senior scientist
Hanne Scholz
Senior scientist
Cellular therapies are being developed as alternatives to tissue and organ therapy in reconstructive medicine. Cell Transplantation is thus a rapidly growing field in medicine. The group is working on the development of pancreatic islet transplantation as a treatment for untreatable type 1 diabetes. This is on the cutting edge of a broad range of therapeutic possibilities.

The research group was established at the Institute of Surgical Research in 2005 and has focused on the development of new strategies to counteract the harmful effects of islet cells before transplantation, and to strengthen islet growth and function after transplantation. In 2009, the first doctorate in the group was published (Tromod Lund) and a master's degree in 2008 (Ingrid Aursnes Stølen).

The research group is part of a Nordic Network for Clinical Islet Transplantation (NNCIT) and works in collaboration with the University of Uppsala, Sweden. During the last few years extensive efforts have been devoted to establishing facilities to isolate and cultivate human islet cells and other cell types, such as hepatocytes and mesenchymal stem cells, to create a center for cell transplantation at Oslo University Hospital.